Autolus Therapeutics PLC (AUTL)
4.19
+0.20
(+5.01%)
USD |
NASDAQ |
May 31, 16:00
4.175
-0.02
(-0.36%)
After-Hours: 20:00
Autolus Therapeutics Accounts Payable (Quarterly): 1.399M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.399M |
December 31, 2023 | 0.103M |
September 30, 2023 | 0.661M |
June 30, 2023 | 3.878M |
March 31, 2023 | 0.353M |
December 31, 2022 | 0.531M |
September 30, 2022 | 0.334M |
June 30, 2022 | 0.162M |
March 31, 2022 | 0.153M |
December 31, 2021 | 0.431M |
September 30, 2021 | 1.462M |
Date | Value |
---|---|
June 30, 2021 | 1.119M |
March 31, 2021 | 2.259M |
December 31, 2020 | 2.263M |
September 30, 2020 | 1.997M |
June 30, 2020 | 0.626M |
March 31, 2020 | 1.057M |
December 31, 2019 | 1.075M |
September 30, 2019 | 2.733M |
June 30, 2019 | 3.143M |
March 31, 2019 | 1.833M |
March 31, 2018 | 3.613M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.103M
Minimum
Dec 2023
3.878M
Maximum
Jun 2023
1.287M
Average
1.066M
Median
Accounts Payable (Quarterly) Benchmarks
Adaptimmune Therapeutics PLC | 6.587M |
Biodexa Pharmaceuticals Plc | 0.40M |
NuCana PLC | 7.277M |
TC BioPharm (Holdings) PLC | 2.434M |
Mereo BioPharma Group PLC | 2.455M |